Lameness after Capromorelin (Entyce) in dogs

22 reports to the FDA describe lameness in dogs given Capromorelin. That is 1.5% of all reports for this medicine, compared with 0.6% across reports for all dog medicines, so it is reported unusually often with this medicine.

22Reports

77%Marked serious

0.0%Recovered

45%Died or euthanised

21 daysTypical onset

How soon it started

Same day

4 20%

1–2 days

2 10%

3–7 days

0 0.0%

1–4 weeks

11 55%

Over a month

3 15%

How the animals did

Still unwell when reported

11 50%

Died

4 18%

Euthanised

6 27%

Not known

1 4.5%

Problems reported at the same time

15 68%

11 50%

10 45%

8 36%

7 32%

6 27%

6 27%

Didn't work as expected

6 27%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Capromorelin stimulates appetite.

Products with this ingredient include Entyce, Elura. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Capromorelin cause lameness in dogs?: 22 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 21 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Lameness with similar medicines

Lameness after Maropitant (Cerenia) 214 reports · 1.8% of its reports

All reported side effects of Capromorelin in dogs · Medicines most reported with lameness